Hot Stocks To Buy For 2019: March 2014

Monday, March 31, 2014

Profit Forecasts Put On Ice For First Quarter

It may officially be Spring, but there's a deep chill running through first quarter earnings forecasts.

When earnings season gets under way next week, profits among S&P 500 companies are expected to post a decline of 0.6% in the first quarter, according to FactSet. That would be the first drop in earnings since the third quarter of 2012 and a marked change of fortunes from forecasts at the start of the year, when analysts had been predicting profits would rise 4.2%. While it's not unusual for analysts to slash earnings forecasts, that's a bigger swing in expectations than is usually the case.

At the same time, companies in the S&P 500 are issuing profit warnings in near record numbers.

Ahead of first-quarter earnings reporting season, 93 companies have warned that profits would fall short of forecasts, according to FactSet's count. That makes it the second-highest overall number of companies issuing negative guidance on record.

But shareholders seem to have been taking these profit warnings in stride. Shares of the companies that warned on first-quarter profits gained an average 0.2% after the news. That's a change from the past five years, when they lost an average 0.8% after a profit warning. And shares of companies saying they will have better-than-expected profits have gained 3.6%, above the average 3% gain over the past five years.

That could be because shares tend to move according to whether companies beat or miss Wall Street's forecasts, so analysts and strategists say that firms have incentive to aim low in their forecasts, strategists and analysts say. And last quarter, which had the strongest profit growth in two years, holds the record for the number of corporate profit warnings.

Hot Small Cap Stocks To Own Right Now

Plus, the average company is warning that profits will fall just 6.7% below Wall Street consensus, FactSet found, below the average of 11% over the past five years.

The sales side is looking brighter as well, with 40 companies warning investors about their first-quarter sales. That's the lowest number since the first quarter of 2012. And Wall Street is forecasting 2.4% of growth in first-quarter sales from last year.

Sunday, March 30, 2014

Sony: All Set for Growth

With the requirement of storage rising, manufacturers of storage media are focused on acquiring a bigger market share. This rise is attributed to the space hungry customers and growth of sales in smart phones, cloud environment and data centers. Sony (SNE) is one company focusing in a bigger bite of the growing storage market and also challenging its various competitors like SanDisk and Samsung on various fronts. Sony has a diverse product portfolio and is also into flash memory storage devices.

Since Sony is manufacturer of various devices and most of these devices need primary or secondary storage. Sony's flash drives and SSD's suffice the requirement of storage in the devices manufactured by Sony, and also as OEM for various other manufacturers. Forward integration of the flash drives and SSD helps Sony to benefit the sales of these storage drives from in house demand.

Sony Mobile is a subsidiary of Sony, it manufactures Smartphones and this has helped growth sales of storage drives manufactured by Sony. The company is also in no doubt for its mobile products and communication (MP&C) growth.

The following factors are driving SSD growth:

New generation Notebooks and Ultrabooks prefer to use SSD rather than conventions HDD. Price decrease of NAND has made SSDs more affordable and hence leading to higher demand. Big data requirement in data centers is also driving SSD growth. Customer's appetite increasing for storage on their Smartphone and tablets

Financial aspects

The Company recently released its Q3-2013 results. The results recorded growth in the revenue. The results are influenced by increased sale of its smartphones and also Play Station 4 that was launched. The revenue increased by 23.9% ($22,979 million) as compared to year ago quarter. The increase was also mainly due to the favorable impact of foreign currency. Sales increased by 5% year-on-year on constant currency basis.

The company's operating income was $860 million which also recorded a growth. The company recorded significant improvement in Home Entertainment and Sound. The losses in the television segment also decreased. The growth in the income mainly was again due to the improvement in all business segments of Sony and launch of PlayStation-4.

Road ahead

Future of any company is always dependant on its past decision and strategies. In recent years, Sony released various models of premium smartphones which did not have any external storage slots. The integration of storage devices helped Sony increase its margins and boost its own in-house demand.

After its recent success in Smartphone's, Sony further plans to expand its portfolio with more Smartphone's and tablets. This means that there will be higher in house consumption of memory cards at Sony.

With PlayStation 4 already recording many success stories the demand for extended memory storage also helps Sony to boost it sales.

Sony also plans to launch new series of Television. It is focused on the high density TV market and the LED TV market. These products will also help Sony with a brighter future and the journey of 2014 seems to be rosy for Sony.

Competitor

Samsung (SSNLF) provides major competition to Sony to acquire market share for many products that are manufactured by both the companies. The company has also launched its latest Smartphone Samsung S5 on 27-Mar-2015 in Indian market, one of the fastest growing smartphone markets in the world. The price of this phone is targeted to be around $850 will be an important factor to compete against Sony Xperia Z2 which is expected to be on a lower price range with almost same features.

Samsung had posted revenue of $54.95 billion, but the operating profit of $7.7 billion was down by 18% from the previous quarter. This decline in profit is for the first time in last two years. Samsungs's major revenue is from its mobile division which again there was a decline in profit.

Conclusion

Sony is placed well in this market through its product innovations, launch and acquisitions. The company is also trading at an inexpensive trailing P/E multiple and analysts are expecting solid growth going forward. Hence, Sony looks like a good investment if you prefer to go for long.

Currently 0.00/512345

Rating: 0.0/5 (0 votes)

Subscribe via Email RSS Feeds

Subscribe RSS Comments Please leave your comment:
More GuruFocus Links

Latest Guru Picks	Value Strategies
Warren Buffett Portfolio	Ben Graham Net-Net
Real Time Picks	Buffett-Munger Screener
Aggregated Portfolio	Undervalued Predictable
ETFs, Options	Low P/S Companies
Insider Trends	10-Year Financials
52-Week Lows	Interactive Charts
Model Portfolios	DCF Calculator
RSS Feed	Monthly Newsletters
The All-In-One Screener	Portfolio Tracking Tool

Saturday, March 29, 2014

Top 5 Medical Companies To Own For 2014

Top 5 Medical Companies To Own For 2014: Stemline Therapeutics Inc (STML)

Stemline Therapeutics, Inc. (Stemline), incorporated on August 8, 2003, is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics that target both cancer stem cells (CSCs) and tumor bulk. The Company is developing two clinical-stage product candidates, SL-401 and SL-701, for which it holds global marketing rights. The indication for SL-401, a biologic-drug conjugate, is acute myeloid leukemia (AML). The indications for SL-701, a synthetic peptide vaccine, are pediatric and adult brain cancer. It has a platform, StemScreen, for the discovery of CSC-targeted compounds, from which it has discovered or validated several of its clinical and preclinical product candidates. Stemline's StemScreen consists of StemScreen-1 and StemScreen-2 for the identification of CSC-directed compounds.

SL-301 is a small molecule gamma-secretase inhibitor that inhibits Notch, a pathway expressed by CSCs and tumor bul k of multiple cancer types. SL-101 is a monoclonal antibody-based (mAb -based) compound that targets CD123 and has shown in vitro activity against certain hematologic cancers. SL-201 is a small molecule active against certain hematologic and solid tumor types. SL-601 is a mAb-based compound that targets a cell surface marker on bladder CSCs, which is also expressed on a variety of other solid tumor types. It has also in-licensed certain intellectual property directed to mAb-based therapeutics to validated oncology targets, including Glypican-3, Tie-1, CD133, Frizzled, Smoothened and Patched.

SL-401 - An IL-3R-Directed Compound Targeting Cancer Stem Cells and Tumor Bulk

SL-401 is a clinically active biologic-drug conjugate consisting of human interleukin-3 (IL-3) genetically linked to a truncated version of diphtheria toxin. SL-401 target! s the IL-3 receptor (IL-3R), which is overexpressed on both the CSCs and tumor bulk of multiple hematologic cancer s, including AML. SL-401 has demonstrated preclinical in vit! ro and in vivo activity against both leukemia blasts (which includes tumor bulk) and CSCs of a range of human leukemia cell lines and primary leukemia cells from patients.

SL-701

SL-701 is a clinically active synthetic peptide vaccine that targets several epitopes on CSCs and tumor bulk of brain cancer. In two completed Phase 1/2 clinical trials, SL-701 demonstrated single agent anti-tumor activity in pediatric patients with newly diagnosed brainstem glioma (BSG) and other high-grade gliomas (HGGs) and in adult patients with refractory or recurrent GBM, and other HGGs.

StemScreen-1

StemScreen-1 is a drug discovery platform designed to identify CSC-targeted compounds based on the isolation of CSCs and evaluation of CSC gene expression profiles. CSCs are isolated from primary tumor tissue or cell lines, and then subjected to gene expression analysis using a variety of technologies, including microarray. A control tissue, such as normal bone marrow is analyzed as a comparator against the gene expression profile of the isolated CSCs. These data are then interfaced with an information base of compounds and their mechanisms of action (that is which gene products and pathways they impact). It has utilized StemScreen-1 to discover a number of its preclinical drug candidates. These include SL-201, SL-301, and SL-601. In addition, SL-401 demonstrated activity against CSCs as determined by both an in vitro colony formation and in vivo animal implantation assay, thereby validating certain StemScreen-1 anti-CSC assays.

StemScreen-2

StemScreen-2 is a high throughput drug discovery platform it is developing to discover anti-CSC compounds. StemScreen-2 utilizes a cell-based assay that can track and follow CSCs in their natural state during high throughput screening! . In part! icular, StemScreen-2 utilizes a CSC-specific promoter linked to a reporter as a method for identifying and follo wing CSCs in their native environment of surrounding tumor b! ulk. In t! his way, StemScreen-2 enables the identification of compound hits, in a high throughput manner, with anti-CSC activity.

The Company competes with Boston Biomedical, Inc., Eclipse Therapeutics, Inc., OncoMed Pharmaceuticals, Inc., Verastem, Inc., Astellas Pharma US, Inc., Boehringer Ingelheim GmbH, Dainippon Sumitomo Pharma Co. Ltd., Geron Corp., GlaxoSmithKline plc, ImmunoCellular Therapeutics, Ltd, Macrogenics Inc., Amgen, Inc., Pfizer Inc., Roche Holding AG, Sanofi U.S. LLC., Cyclacel Pharmaceuticals, Inc., Sunesis Pharmaceuticals Inc., Clavis Pharma ASA, Ambit Biosciences Corporation, Celgene Corporation, Eisai Co. Ltd., Celator Pharmaceuticals, Inc., Merck & Co., Inc., Eisai Co., Inc., Roche Holding AG, Novartis AG and Celldex Therapeutics, Inc.

Advisors' Opinion:

[By Jay Silverman]
Some of the biggest leaders in that field, and there have been dozens in fields, if not more this year, such as Bluebird (BLUE) and Stemline Therapeutics (STML) and have all pulled back to significantly lower levels; even below, in Bluebird's case, the price that had actually opened up as an IPO, even though it's above its IPO price.
[By David Zeiler]
3. Stemline Therapeutics Inc. (Nasdaq: STML): This biotech develops drugs that target cancer stem cells and tumors. Stemline went public January 29 at $10 a share and rose just 11.78% on its first day. But STML has climbed steadily since, and currently trades at $37.46, up 274.6% from its IPO price.
[By Keith Speights]
Best-performing biotech IPO
Stemline Therapeutics (NASDAQ: STML ) has only traded publicly this year, but what a year it's been. The stock's performance ranks Stemline as the best-performing biotech IPO so far in 2013. This week has been pretty good also,! with sha! res moving up by 28%.

source from Top Stocks Blog:http://www.topstocksblog.com/top-5-medical-companies-to-own-for-2014.html

Thursday, March 27, 2014

Obamacare tops 6 million signups

Obamacare has hit 6 million signups.

NEW YORK (CNNMoney) More than 6 million people have signed up for Obamacare, as a crush of people raced to get health insurance before the March 31 deadline.

President Obama announced the milestone Thursday in a call with enrollment counselors and outreach volunteers, who are undertaking an intense marketing drive in the final days of open enrollment. There were more than 1.5 million visits to HealthCare.gov and more than 430,000 calls to the call centers on Wednesday.

Those who've started the application by next Monday but are unable to finish because of technical issues will receive more time to complete the process, officials have said.

Reaching 6 million is a symbolic victory for the Obama administration following the botched launch in October.

It is short of the initial goal of 7 million, which was based on a projection by the Congressional Budget Office and adopted by the administration. But it shows considerable gains from the first month when just 106,000 people had signed up.

Last month, the CBO revised its projection down to 6 million because of the rocky initial rollout.

But just how many people fully enroll in the program this year remains to be seen. The latest figures reflect those picking plans, not paying their premiums. Only those who pay their first month's premium are considered enrolled, while those who don't pay have their policy selections canceled.

Insurers have said that the share of people sending in payments is in the 80% range.

How Obamacare insurance exchanges work

Also, the total number of enrollees nationwide is not that important a number, experts have said. What's more critical is whether enrollment meets each insurer's expectations since that's what will determine premiums for next year. Insurers are looking at both how many people pick their policies and how many claims they file.

Many experts are watching the share of young adults picking plans since they are considered healthier and less costly than older enrollees. Some 25% of those signing up are between ages 18 to 34, as of the end of February, the latest figures available. The White House and independent experts had forecast about 40% would be young adults.

Wednesday, March 26, 2014

5 Retail Stocks Suffering Markdowns

Popular Posts: 5 Mining Stocks to Buy Amid the Surge in Silver and Gold3 ETFs to Buy When the Dollar Falls3 Breakout Gold Stocks to Buy Recent Posts: 5 Retail Stocks Suffering Markdowns 3 Reasons the Selloff Isn’t Finished 3 Breakout Gold Stocks to Buy View All Posts

While the S&P 500 trades just below record highs, continuing a month-long sideways slide just below the 1,880 level, a growing swath of the market is coming under intensifying selling pressure.

retail shopping display1 5 Retail Stocks Suffering Markdowns

Source: Flickr

Consider that the small caps in the Russell 2000 are on track for their fourth-consecutive decline on Wednesday as the index rolls down its lower Bollinger Band for the first time since the start of the January selloff. That’s a big warning sign flashing red. All is not well within the market.

One by one, cyclical economically-sensitive sector groups are rolling over. Big tech and biotech have been the biggest laggards recently. But retail stocks are now rolling over after J. Crew noted concern over weak traffic trends on Tuesday, bringing out the sellers in a big way.

As a result, the Retail SPDR (XRT) is looking about as appealing as a cold shower, falling out of its month-long trading range on a surge of negative volume. Here are five industry stocks you need to avoid, or could even consider playing on the short side:

American Eagle Outfitters (AEO)

American Eagle Outfitters (AEO) is falling below support from its October and January lows after recently suffering a series of analyst downgrades after issuing disappointing forward guidance earlier this month.

AEO chart 5 Retail Stocks Suffering Markdowns
Click to Enlarge

AEO stock has fallen 13% year-to-date, and conditions aren’t exactly looking up for the stock. The company is looking for a “high single digit decline” in same-store sales in the first quarter amid challenging conditions.

That’s hardly a unique problem, but it will put further pressure on AEO stock.

Gap (GPS)

Gap (GPS), which was a strong performer throughout 2012 and 2013, has stalled out over the last nine months and is rolling over once more.

GPS chart 5 Retail Stocks Suffering Markdowns
Click to Enlarge

GAP stock has lost its 50- and 200-day moving averages for the first time since December after the company reported a sharp (-7%) drop in February same-store sales. This follows on disappointing guidance for full-year 2014 issued back in February.

And with retail headwinds as strong as they’ve been, there’s no relief in sight for GAP stock.

Express (EXPR)

Express (EXPR) has been in meltdown mode since issuing disappointing guidance back in December, ending a strong uptrend that started in late 2012.

EXPR chart 5 Retail Stocks Suffering Markdowns
Click to Enlarge

This was followed by a top- and bottom-line miss on quarterly results earlier this month, as well as another batch of weak guidance. A return to the 2012 support lows would be worth a 30%+ drop from current levels.

Given that news, EXPR stock is in store for long-term troubles.

Amazon (AMZN)

Amazon (AMZN) is suffering from the selling pressure hitting both big tech stocks as well as retailers.

AMZN chart 5 Retail Stocks Suffering Markdowns
Click to Enlarge

The company, which is struggling to make its revenue-growth-at-all-costs model actually turn a profit, is threatening to fall through its February support lows in what could potentially be the first major breakdown for the stock since late 2011.

Amazon’s troubles show that not even internet retailers are immune to the challenges in the retail sector.

Home Depot (HD)

Home Depot (HD), which posted an epic rise in 2012, is rolling over after tracing out a double-top formation near $82 over the last few months.

HD chart 5 Retail Stocks Suffering Markdowns
Click to Enlarge

HD stock is vulnerable to the pressure building in the housing market amid the rise in long-term interest rates. Already, mortgage origination activity has crashed below 2008 financial crisis lows. Less transaction volume means less home renovation spending, which will pull HD down from its lofty valuation.

A return to the September low would be worth a near 10% decline from here.

Disclosure: Anthony has recommended AMZN put option positions to his clients.

Anthony Mirhaydari is founder of the Edge and Edge Pro investment advisory newsletters, as well as Mirhaydari Capital Management, a registered investment advisory firm.

Tuesday, March 25, 2014

10 Best Growth Stocks To Invest In 2014

10 Best Growth Stocks To Invest In 2014: Nordstrom Inc.(JWN)

Nordstrom, Inc., a fashion specialty retailer, offers apparel, shoes, cosmetics, and accessories for women, men, and children in the United States. It offers a selection of brand name and private label merchandise. The company sells its products through various channels, including Nordstrom full-line stores, off-price Nordstrom Rack stores, Jeffrey? boutiques, treasure & bond, and Last Chance clearance stores; and its online store, nordstrom.com, as well as through catalog. Nordstrom also provides a private label card, two Nordstrom VISA credit cards, and a debit card for Nordstrom purchases. The company?s credit and debit cards feature a shopping-based loyalty program. As of September 30, 2011, it operated 222 stores, including 117 full-line stores, 101 Nordstrom Racks, 2 Jeffrey boutiques, 1 treasure & bond store, and 1 clearance store in 30 states. The company was founded in 1901 and is based in Seattle, Washington.

Advisors' Opinion:

[By Ben Levisohn]
Shares of Dillard’s have dropped 1.4% to $89.99 at 3:13 p.m., while Macy's (M) has dropped 0.6% to $57.33, Sears Holdings (SHLD) has fallen 2.7% to $44.61 and Nordstrom (JWN) has has dipped $61.59. JC Penney is little changed at $8.29.
[By Marc Bastow]
Fashion specialty retailer Nordstrom (JWN) raised its quarterly dividend 10% to 33 cents per share, payable March 25 to shareholders of record as of March 10.
JWN Dividend Yield: 2.15%
[By Grace L. Williams]
The hits keep coming at high-end retailer Nordstrom (JWN).
Bloomberg
After reporting a decline in fourth-quarter earnings and weak sales, shares traded down 0.3% to $59.24 today. And Sterne, Agee & Leach's Charles Grom, while acknowledging that the fourth quarter was "OK," warned that there were issues developing undern! eath. He explains:

Beneath the surface, there are two disturbing trends emerging that shouldn't go unnoticed, including: 1) a more promotional environment/gross profit margin risk (as Nordstrom price matches); and 2) full line cannibalization (via e-commerce), which structurally compresses Nordstrom's top-line algo. All told, the Nordstrom experience is one of the best in retail, but the stock is dead money for the foreseeable future, in our view.

Grom accentuated a few positives that included a rise in same-store sales by 2.6% and decent earnings. A rise in inventory levels and lower EPS guidance were some of the negatives, Grom said.

Nordstrom’s pain didn’t cause stand in the way of gains for some other department store stocks. Dillard’s (DDS) gained 1.5% to $89.33, while Macy’s (M) rose 0.5% to $53.71. Even J.C. Penney (JCP) had a better day. It finished down just 0.2% at $5.64.

source from Top Stocks Blog:http://www.topstocksblog.com/10-best-growth-stocks-to-invest-in-2014.html

Monday, March 24, 2014

Bank Winners and Losers

When the Federal Reserve releases Round Two results of its stress test this week, several US banks stand to benefit, while others do not, and MoneyShow's Jim Jubak analyzes which banks may be the victors, and why.

So what US banks will be the winners—and which the losers—when the Federal Reserve releases Round Two of its stress test data on March 26?

Last Thursday's Round One looked at 30 big US banks to see which met the Fed's capital targets in the event of a US financial and economic crisis. Only Zions Bancorp (ZION) rallied to meet the Fed's target. In the event of a crisis, Zion's capital ratio would fall to 3.5%. That's below the 5% minimum set by the Fed.

Friday, Wall Street moved on to look at this week's test. On Wednesday, the US central bank will announce which of the 30 banks on the list have won approval for their capital plans for 2014. Banks winning approval will be able to go ahead with plans for share buybacks and increased dividend payouts. Banks that fail to win approval will have to put buybacks and dividend payouts (or, at least, increases in dividend payouts) on hold while they resubmit plans for raising capital and for distributing it to shareholders.

Zions Bancorp isn't the only bank in danger of getting a "No" from the Fed this week. Bank of America (BAC), Morgan Stanley (MS), Goldman Sachs (GS), and JP Morgan Chase (JPM) all came in with capital ratios below 7% in the Fed's test. That puts them relatively close to the 5% limit and might lead the Fed to veto their plans for buybacks and dividend increases. Last year, the Fed gave an initial "No" to both Bank of America and Citigroup (C). (Citigroup is a member of my Jubak's Picks portfolio.)

The capital ratio under the Fed's stress test isn't a straightforward indicator of how the Fed will rule. The central bank will also consider the capital distribution plans submitted by individual banks and how much capital buffer any plan would leave. For example, the consensus among Wall Street analysts is that the Fed will approve the plan from JPMorgan Chase, because it projects distributing only about $10 billion from the bank's $17 billion capital buffer above the Fed's stress test minimum.

The consensus also points to Bank of America as the closest to a potential veto. The Fed's stress test showed the bank generating a loss of $49.1 billion in that scenario. That's the biggest stress test scenario loss among the 30 banks.

The Fed will also take into account its judgment of the accuracy of a bank's own capital planning. Here a bank that has produced results from its own models, that are more positive than those of the Fed, may actually wind up at a disadvantage.

So, for example, one reason to think the Fed will approve JPMorgan Chase's capital distribution plan is that the bank's own projections for its capital ratio under the Fed's stress test scenario were almost identical with those produced by the Fed. The difference was scant 0.2 percentage point. Morgan Stanley's in-house projections were, on the other hand, 2 percentage points more optimistic than the Fed's numbers. Bank of America came in 2.6 percentage points above the Fed's scenario.

With analysts estimating that the Bank of America capital plan looks at returning $6 billion to $7 billion to shareholders and with the Fed estimating that the bank has only $6.5 billion in excess capital under its stress scenario, you can see why the bank tops the list of potential Fed capital plan vetoes in this week's Round Two.

Full disclosure: I don't own shares of any of the companies mentioned in this post in my personal portfolio. When in 2010 I started the mutual fund I manage, Jubak Global Equity Fund, I liquidated all my individual stock holdings and put the money into the fund. The fund may or may not now own positions in any stock mentioned in this post. The fund did not own shares of any stock mentioned in this post as of the end of December. For a full list of the stocks in the fund see the fund's portfolio here.

Toyota to pay $1.2B to settle criminal probe

The Justice Department announced Wednesday that Toyota will pay $1.2 billion to settle a criminal probe of its handling of the reports of unintended acceleration in its vehicles and subsequent recalls beginning in 2009.

The settlement -- the largest criminal penalty imposed on a car company in U. S. history -- was announced by the Justice Department and Toyota this morning.

"Today we can say for certain that Toyota intentionally concealed information and misled the public about the safety issues behind these recalls," Attorney General Eric Holder said in announcing the settlement.

"Put simply, Toyota's conduct was shameful," he said.

The investigation was spearheaded by the U.S. Attorney's office and FBI in New York.

CRIMINAL PROBE: Key documents released in Toyota settlement

FIRST TAKE: Toyota's quagmire comes to an end as GM's just gets started

Christopher Reynolds, chief legal officer, Toyota Motor North America, said in a statement this morning: "Entering this agreement, while difficult, is a major step toward putting this unfortunate chapter behind us. We remain extremely grateful to our customers who have continued to stand by Toyota.."

The settlement calls for the government to ultimately dismiss its case in exchange for Toyota's payment and continued cooperation. The deal also calls for an independent monitor how Toyota handles safety communications, its internal handling of accident reports and its processes preparing and communicating technical bulletins.

Toyota says it will record $1.2 billion in after-tax charges against earnings in the fiscal year ending March 31.

Some independent safety watchdogs sounded impressed.

The "settlement with Toyota is a game changer," says Clarence Ditlow of the Center for Auto Safety. "Until today, auto makers faced insignificant fines and no criminal penalties under the Vehicle Safety Act."

He points out, too, that if Toyota doesn't follow through, executives will face the threat of prison! .

The federal criminal probe was independent of lawsuits and federal safety regulator and congressional probes of the Toyota sudden acceleration recalls and looked strictly at whether Toyota provided false or incomplete statements to the National Highway Traffic Safety Administration. It also looked at how it handled complaints.

Toyota has already paid at least $1.6 billion to car owners for lawsuits in the cases and paid federal fines of $16.375 million in 2010 and a $17.35 million fine in 2012 for delays in safety defect reporting to NHTSA.

"While the (criminal probe) price tag represents a costly resolution, Toyota can put this issue behind it to fully focus on current and future challenges in a highly competitive market," says Karl Brauer, senior analyst for Kelley Blue Book, in a statement.

The cases involve instances in which Toyota accelerated when the drivers did not intend it, in essence, becoming runaway cars. After an off-duty California Highway Patrol officer and three passengers in a Lexus ES were killed near San Diego in 2009, other reports surfaced.

Toyota blamed floor mats that can jam under the gas pedal and potentially sticky accelerator mechanisms in several models and did multiple recalls covering both problems.

Best Biotech Stocks To Watch Right Now

Safety experts also alleged that there were problems with the vehicles' engine electronics. But an extensive investigation by federal safety regulators found no evidence that that the electronics were at fault for unintended acceleration.

Still, some are unsatisfied.

"The coverup is still there on the electronics issue," says Sean Kane, an auto safety expert for Safety Research and Strategies. "This (government penalty) sends an important message, but it's a mixed message."

On one hand, he says, automakers are being told they need to be more diligent on safety issues and reporting them or ! face seve! re fines. On the other, government investigators never pushed engineering analyses hard enough to find the root cause of the sudden acceleration cases.

Reynolds said in his statement, however, that Toyota has retooled in the wake of the recalls. "We have made fundamental changes across our global operations to become a more responsive company – listening better to our customers' needs and proactively taking action to serve them."

Sunday, March 23, 2014

The Rise of Aussie Retail

As the Australian resource boom wanes, the country's policymakers have been hoping non-mining sectors would start to assert themselves. With interest rates at historic lows, the housing sector has been one area of obvious strength, though there are concerns that a bubble could be developing.

Surprisingly, the latest retail sales data suggest that this sector could be another source of strength for the economy, as well as yet another hopeful sign that the country's sluggish economy is finally regaining momentum.

This week, the Australian Bureau of Statistics (ABS) reported that January retail sales rose a seasonally adjusted 1.2 percent month over month, to AUD22.9 billion, trouncing the consensus forecast of 0.4 percent. And December's number was revised higher by two-tenths of a percentage point, to 0.7 percent. On a year-over-year basis, retail sales were up 6.2 percent.

Best Gas Stocks For 2014

This was the ninth straight month in which retail sales have risen and the third consecutive month in which the percentage increase has been equal to or greater than the preceding month. Over the past three years, retail sales growth has averaged 0.3 percent monthly growth, while over the trailing six months it's averaged 0.8 percent monthly growth.

So clearly this upward trend, which we first wrote about in early January, has been sustained. The question is whether consumers will continue spending at this pace. While Australia's unemployment rate, which rose to 6.0 percent in January, is enviable from our perspective, it's actually at a 10-year high. And the Reserve Bank of Australia (RBA) expects unemployment to continue rising in the near term.

As evidenced by a recent sentiment survey, consumers are worried about their job security, which could constrain spending in the months ahead. The Westpac-Melbou! rne Institute Index of Consumer Sentiment declined by 0.7 percent in March, to 99.5. That's its lowest reading since last May, and well off the euphoria (or, more likely, relief) that coincided with the country's federal elections in September, when the index had a reading of 110.63.

The sub-index that gauges consumers' outlook for the economy over the next 12 months continued to decline, falling 4 percent month over month. Westpac notes that this measure is now down 21.8 percent year over year, at its lowest level since December 2011, at the height of the European sovereign-debt crisis.

While sentiment is rosier regarding improvement in family finances over the past year, again the outlook shows concern about the year ahead, with this sub-index down 7.1 percent year over year. However, Westpac says this measure, as well as the one concerning whether the time is right to buy a major household item, have both been relatively resilient in recent months compared to the overall sentiment index, even if both have eroded during that time.

This suggests that the gloomy near-term view of the economy has yet to translate into greater caution regarding spending.

To be sure, sentiment tends to be a lagging indicator, as respondents' views are often formed by extrapolating the recent past into the future. However, this survey was taken in early March, while the retail sales data we're analyzing are from January, so the positive trend in retail sales could have at least a short-term hiccup.

On the other hand, the strength in retail sales has been broad-based, particularly with regard to discretionary spending. Spending on restaurants and take-out rose 2 percent sequentially, and sales at department stores were up 2.6 percent. Spending on household goods was also robust, with sales increasing by 1.5 percent.

Still, despite the duration of this trend, analysts remain cautious about the latest data, in part because of seasonality. For instance, JPMorgan analyst Ben Jarman a! ttributed! the surprise result to a boost from the timing of payments from the federal government.

But when viewing these data in tandem with the upside surprise from fourth-quarter gross domestic product (GDP) growth, there's at least a kernel of hope that growth in the year ahead could continue to outpace muted expectations.

Saturday, March 22, 2014

3 insights on Putin from USA's wisest Cold warrior

In 1947, a talented Foreign Service Officer named George Kennan wrote "The Sources of Soviet Conduct" for the journal Foreign Affairs. The ideas expressed in that highly influential essay became the foundation of future Cold War strategy for the United States. I believe much of Kennan's thinking remains relevant today.

Vladimir Putin's Russia is not quite the same as the Soviet Union, of course. The Soviet leadership in 1947 believed in a deterministic Marxist-Leninist ideology that held that communism would inevitably triumph over capitalism. Stalin felt he could afford to be patient.

Like Stalin, however, Putin appears to be embarking on a policy of strategic expansion along Russia's borderlands. Just the other day during a speech in the Kremlin, Putin spoke of the breakup of the old Soviet Union:

Millions of people went to bed in one country and awoke in different ones, overnight becoming ethnic minorities in former Union republics, while the Russian nation became one of the biggest, if not the biggest ethnic group in the world to be divided by borders.

This statement provides a not so subtle clue that further expansion by Putin's Russia is a very real possibility. Here are three insights gleaned from George Kennan, as the United States develops its response to the annexation of Crimea and the possibility of future Russian attempts to revise its borders.

1. Trying to appear "tough" will not be successful. Kennan, who first formulated the American policy of containment, favored a long-term, patient response to Soviet expansion, and was highly critical of "threats or blustering or superfluous gestures of outward 'toughness.' " Having devoted his life to studying Russian history and diplomacy, he believed that it was unwise to put a Russian government in a position where it could not "afford to yield."

Indeed, Kennan believed that losing our self-control would be seen as a sign of weakness that Russian leaders would try to exploit. The wise approach, according to Kenna! n, would be to firmly challenge Russian policy in a way that would leave the way open for "a compliance not too detrimental to Russian prestige."

2. A long-term strategy is essential. In response to Soviet expansion, Kennan envisioned a 10- to 15-year strategy that would allow the U.S. to leverage its considerable economic advantages. From an economic perspective, the Soviet Union was "by far the weaker party" and a long-term policy might expose deficiencies in its economy and society.

Top 5 Gold Stocks For 2014

Similarly, the Russian economy today may struggle in the face of long-term sanctions and the withdrawal of Western investment. America and the West do not appear to have much leverage in the near term for preventing, say, Russian moves into eastern Ukraine. Over a longer period, however, the calculus might be different.

3. Putin's power might not be as secure as it seems. In the Kremlin speech, Putin made a compelling case for the popularity of his expansionary policy. He noted that 95% of Russians supported protecting ethnic Russians in Crimea. And 92% supported Crimea's reunification with Russia.

Kennan wisely advises that we should be somewhat skeptical of the support for authoritarian regimes, believing -- in the case of the Soviet Union -- that it contained "within it the seeds of its own decay." Today, it may appear that Putin's recent moves are quite popular, though it's hard to know what all of the people really think. Recent history suggests that undemocratic leaders are often not as popular as they appear.

What does this mean for investors?

Kennan's ideas appear to offer a compelling way for the United States to counter Putin's increasingly aggressive foreign policy. We may not be headed for another Cold War, but it is highly likely that relations between the U.S. and Russia will be strained for some time.

Recently, White House spokesman Jay Carney underlined th! at point ! by saying, "I wouldn't, if I were you, invest in Russian equities right now unless you were going short." And earlier this week, Reuters revealed that the SEC reached out to investment companies with investments in Russia to make sure they were "properly managing their risks and disclosing their holdings to investors." Finally, Bloomberg has reported that General Electric (GE) and Boeing (BA) are growing increasingly concerned about events in Russia. Both companies have considerable investments there, and are worried that Russian retribution in response to U.S. sanctions could hurt their businesses.

It would be wise for investors to understand their exposure to Russia -- whether it's via mutual funds or in the equities of large multinationals. The near-term risks appear quite high, and are unlikely to ease anytime soon, in my opinion.

Should President Obama reconsider?

President Obama recently told an interviewer "I don't really even need George Kennan right now." I think that belief is unwise. No one understood Russia better than Kennan. Even though he is no longer alive, we still have his thoughtful writings on Russia and his diplomatic efforts to guide us.

In conclusion to his essay in Foreign Affairs -- in grand language that evokes another era in our history -- he provided an inspirational call to action. Kennan wrote that we shouldn't complain about the challenge posed by the Kremlin. Instead, he believed the thoughtful observer should:

...experience a certain gratitude to a Providence which by providing the American people with this implacable challenge, has made their entire security as a nation dependent on their pulling themselves together and accepting the responsibilities of moral and political leadership that history plainly intended them to bear.

Obviously, those words were written in a different time under different circumstances. But I think we can benefit from the spirit of those remarks. George Kennan still has much to teach us.

The Motley Fool! is a USA! TODAY content partner offering financial news, analysis and commentary designed to help people take control of their financial lives. Its content is produced independently of USA TODAY.

&amp;amp;amp;lt;SCRIPT language='JavaScript1.1'SRC="http://ad.doubleclick.net/adj/N4538.USAToday/B2304017.8;abr=!ie;sz=550x300;ord=[timestamp]?"&amp;amp;amp;gt;&amp;amp;amp;lt;/SCRIPT&amp;amp;amp;gt;&amp;amp;amp;lt;NOSCRIPT&amp;amp;amp;gt;&amp;amp;amp;lt;AHREF="http://ad.doubleclick.net/jump/N4538.USAToday/B2304017.8;abr=!ie4;abr=!ie5;sz=550x300;ord=[timestamp]?"&amp;amp;amp;gt;&amp;amp;amp;lt;IMGSRC="http://ad.doubleclick.net/ad/N4538.USAToday/B2304017.8;abr=!ie4;abr=!ie5;sz=550x300;ord=[timestamp]?" BORDER=0 WIDTH=550 HEIGHT=300ALT="Advertisement"&amp;amp;amp;gt;&amp;amp;amp;lt;/A&amp;amp;amp;gt;&amp;amp;amp;lt;/NOSCRIPT&amp;amp;amp;gt;

Friday, March 21, 2014

Stocks: Set to close week with a gain

Click on chart to track premarkets

NEW YORK (CNNMoney) This week saw tweaks to Federal Reserve policy, rising tensions between the West and Russia and continued concerns about slowing growth in China.

But for the most part, markets kept pushing higher. As it stands now, the major U.S. indexes look set to close out the week with a healthy gain.

U.S. stock futures were edging up Friday, with investors feeling relatively calm after a Fed freak out in the middle of the week.

Stocks could be volatile Friday as it's also the day when four futures and options contracts expire -- known as quadruple witching.

"That's the main driver of the day," said Peter Cardillo, chief market economist at Rockwell Global Capital. "There is really no economic news out there other than the fact that there was some good news out there last night on the [Federal Reserve's] stress test: 29 of the 30 big banks passed."

Best Safest Stocks To Buy For 2014

Markets were rattled Wednesday after Fed chair Janet Yellen suggested that the central bank could begin hiking interest rates sooner than expected. But stocks have climbed every other day this week.

The latest reading on the CNNMoney Fear & Greed index shows markets are getting greedy again.

But the mood isn't quite so perky in Russia, where the stock market and ruble are under pressure after the U.S. announced sanctions against more high-ranking Russian individuals and a bank. Western nations are trying to put pressure on Russia after it annexed Crimea, a region in southern Ukraine.

There's little U.S. economic or corporate news on the docket Friday. Before the bell, Tiffany (TIF) reported full-year earnings and sales that fell sho! rt of forecasts.

Shares of Nike (NKE, Fortune 500) slid 3% after the company said earnings could be squeezed over the next few quarters.

Shares of Symantec (SYMC, Fortune 500) plunged after the company fired its CEO.

European markets were all rising in morning trading.

Asian markets mostly closed with gains. The main stock market indexes in Hong Kong and China pushed higher.

The Nikkei in Japan was closed for the Vernal Equinox.

Thursday, March 20, 2014

Top 10 Medical Companies To Buy For 2014

Top 10 Medical Companies To Buy For 2014: Intrexon Corp (XON)

Intrexon Corporation, incorporated on April 19, 2004, is engaged in the business of synthetic biology. Using the Company's suite of complementary technologies, it design, build and regulate gene programs, or sequences of deoxyribonucleic acid (DNA) that control cellular function, and cellular systems, or activities that take place within a cell and the interaction of those systems in the greater cellular environment, to enable the development of new and improved products and manufacturing processes across a variety of end markets, including healthcare, food, energy and environmental sciences. Its technologies include the UltraVector gene design and fabrication platform; Cell Systems Informatics; LEAP-cell identification and selection, and mAbLogix-antibody discovery.

The Company's LEAP technology facilitates the automated identification of an individual cell with the highest levels of expression, quality and potency from a population of over 100,000 cells. Its mAbLogix platform complements UltraVector with a library of human antibodies that exceeds 500 million. By immortalizing human tonsils, which consists of lymphatic tissue containing B-cells, its mAbLogix platform creates a B-cell library that can generate antibodies against an almost infinite number of new antigens.

The UltraVector gene design and fabrication platform

The Company's gene program design platform, which it refer to as UltraVector, is an integrated suite of tools comprising advanced DNA construction technology and components, cellular and protein engineering tools, computational models and statistical methods which facilitate the rapid design, build and testing of complex systems. The UltraVector platform allows the Company to translate gene programs into standard components that can be designed, manufactured and tested in an aut! omated format. This technology enables it to engineer at the cellular level from biological sources.

UltraVector DNA design is computer-automated and ! utilizes a set of defined construction rules to assemble components that are stored in its DNA library. In addition to the number of gene components in its UltraVector library, it is designing and creating enzymatic and regulatory components that provide control over genome integration and gene regulation. Its RheoSwitch Therapeutic System is a three-component transcriptional regulator that provides inducible gene expression. The RheoSwitch Therapeutic System provides the ability to not only express proteins/enzymes of interest, but also the ability to control the level and timing of expression to achieve a biological outcome. Other ongoing programs include its Attsite recombinases, which mediate predictable gene exchange into host cells thereby eliminating many of the difficulties seen with traditional gene insertion.

Cell Systems Informatics

The Company's Cell systems informatics permits design, as well as testing and learning about new gene tar gets or product pathways. Its bioinformatics software and database systems for mapping cellular pathways when combined with its genome-scale modeling and experimental data, including, gene expression profiling and protein engineering, enable the Company to optimize selection and development of gene programs and cellular systems for its collaborators. Its computational modeling and simulation platform enables the development of predictive computer models of organisms, from microbes to humans. This platform builds virtual cells from their basic molecular components, and can simulate the activity of the cell's complete reaction network.

The Company is designing proteins with post-translational modifications. It is also working to develop enzyme inhibitors and fusion proteins for a variety of applications in human and animal therapeutics. Its protein engin! eering ma! y utilize one or more of its technologies to obtain catalysis activitiesits component library, the g eneration of component variants sequence, evolutionary analy! sis and s! tructure-based sequence alignment, computer-aided drug discovery, de novo, or synthesized or generated, and comparative protein modeling, molecular dynamics simulation and free energy analysis, antibody design and humanization, antigenicity prediction, protein pharmacokinetics optimization, and/or in silico support of enzyme engineeringand quantitative structure-function relationships with machine learning algorithms to optimize, facilitate and prioritize protein variant libraries for the advancement of its collaborators.

LEAP-cell identification and selection

The Company's Laser-Enabled Analysis and Processing technology (LEAP), is an instrument that merges semiconductor manufacturing technologies for cell processing applications to provide high levels of control and scale to cell purification and stem cell culture management. The LEAP platform can identify and purify cells of interest from large libraries of cells created by its UltraVector and bioinformatics technologies using a laser-based purification process, thereby providing a mechanism of testing the degree of protein expression in genetically modified cells, as well as means to learn from the genetic building process.

mAbLogix- antibody discovery

The Company's mAbLogix antibody discovery platform, or mAbLogix platform, enables production of B-cell libraries for discovery of antibodies. The mAbLogix platform permits antigen targeting using fully human monoclonal and polyclonal antibodies. Its mAbLogix antibody discovery process consists of two major activities: the build of human B-cell libraries expressing a large number of antibodies, and the testing of these libraries based on an analysis of B-cells that express antibodies in response to a chosen antigen.

The Company competes with AbD SeroTec, Alex! ion Pharm! aceuticals, Inc., XOMA Corporation, Genmab US, Inc., MorphoSys AG, NovImmune SA, Societe Des Systemes Biologiq ues, Adimab, LLC, ProMab Biotechnologies, Inc., Abpro, Inc.,! AIIM The! rapeutics and Open Monoclonal Technology, Inc.

Advisors' Opinion:

[By John Udovich]
Bubble talk, biotech IPO setbacks plus news about small cap biotechs like Intrexon Corp (NYSE: XON) and TNI BioTech (OTCMKTS: TNIB) have dominated biotech news this week or in recent weeks. Just consider the following news:
[By Jon C. Ogg]
Intrexon Corp. (NYSE: XON) was started as Buy at Mizuho Securities, started as Equal Weight at Barclays and started as Overweight at J.P. Morgan.

Nokia Corp. (NYSE: NOK) was raised to Hold from Sell at Deutsche Bank, raised to Neutral from Underperform at Credit Suisse and
Canaccord Genuity raised its price target to $5.50 from $3.30.
[By Ben Levisohn]
Overvalued companies include MWI Veterinary (MWIV) and Stericycle (SRCL), while companies with attractive valuations include Cardinal Health (CAH), Selected Medical (SEM). He’s not a fan of Intrexon (XON) but calls Aratana (PETX) a “hidden gem.”

source from Top Stocks Blog:http://www.topstocksblog.com/top-10-medical-companies-to-buy-for-2014.html

Wednesday, March 19, 2014

Best Undervalued Stocks To Watch Right Now

Best Undervalued Stocks To Watch Right Now: Caterpillar Inc.(CAT)

Caterpillar Inc. manufactures and sells construction and mining equipment, diesel and natural gas engines, industrial gas turbines, and diesel-electric locomotives worldwide. It operates through three lines of businesses: Machinery, Engines, and Financial Products. The Machinery business offers construction, mining, and forestry machinery, including track and wheel tractors, track and wheel loaders, pipelayers, motor graders, wheel tractor-scrapers, track and wheel excavators, backhoe loaders, log skidders, log loaders, off-highway trucks, articulated trucks, paving products, skid steer loaders, underground mining equipment, tunnel boring equipment, and related parts. It also manufactures diesel-electric locomotives; and manufactures and services rail-related products and logistics services for other companies. The Engines business provides diesel, heavy fuel, and natural gas reciprocating engines for Caterpillar machinery, electric power generation systems, marine, petrol eum, construction, industrial, agricultural, and other applications. It offers industrial turbines and turbine-related services for oil and gas, and power generation applications. This business also remanufactures Caterpillar engines, machines, and engine components; and offers remanufacturing services for other companies. The Financial Products business provides retail and wholesale financing alternatives for Caterpillar machinery and engines, solar gas turbines, and other equipment and marine vessels, as well as offers loans and various forms of insurance to customers and dealers. It also offers financing for vehicles, power generation facilities, and marine vessels. The company markets its products directly, as well as through its distribution centers, dealers, and distributors. It was formerly known as Caterpillar Tractor Co. and changed its name to Caterpillar I! nc. in 1986. Caterpillar Inc. was founded in 1925 and is headquartered in Peoria, Illinois.

Advisors' Opinion:

[By Ben Levisohn]
With little in the way of local news to move the market today, US stocks are taking their cues from overseas — and they don’t like what they see, leaving Boeing (BA), Nike (NKE), Caterpillar (CAT), United States Steel (X) and Peabody Energy (BTU) in the red.
[By Patricio Kehoe]
The concept of diversity, when talking about a company's activities, is a sword with two edges. When performance hits the fan, diversity can turn into an advantage as only one segment can be affected. However, diversification can curtail winnings during a moment of bonanza. In other words, a company with five segments will see a relative smaller impact in overall performance than a company with activities in a single segment, when that segment experiences an abnormal growth. Hence, with a recovering construction market in the US and declining prices for mined commodities, a comparison between Caterpillar (CAT) and Terex (TER) is all the more relevant.
[By Paul Ausick]
Today's big gainer among the Dow stocks was Caterpillar Inc. (NYSE: CAT). Competitor Joy Global Inc. (NYSE: JOY) reported rotten results this morning, largely due to anemic sales to coal miners. Caterpillar doesn't do a lot of business with coal companies, so that's a plus the firm. Cat's shares traded up 1.4% at $97.71 in a 52-week range of $84.79 to $98.24 just ahead of the closing bell. Volume is on track to be about 25% below the daily average of around 6 million shares traded.

source from Top Stocks Blog:http://www.topstocksblog.com/best-undervalued-stocks-to-watch-right-now-2.html

Monday, March 17, 2014

Best Up And Coming Stocks To Watch For 2014

There are 315 million people and 13 million businesses in America. The tax code is 73,000 pages long. Visa and MasterCard process 4,000 transactions per second. Forty-seven million Americans are on food stamps, the 400 richest Americans are worth $2 trillion, 254 million antidepressant prescriptions are written annually, and in the time it took me to write this paragraph 13 Americans filed for bankruptcy, 22 were married, and 21 died.

The economy is so complex is it literally unfathomable. There are trillions of moving parts reacting to each other every second, often without making any sense or having any historical precedent.

One of the most dangerous things you can do is pretend the economy, or the stock market, is simple and easy to understand. It causes you to see patterns that are really just random flukes, and wrongly assume that if one lever is pulled over here, something predictable will happen over there. This is one reason clueless, passive investors often outperform professional ones. Clueless investors aren't tempted by false-insight masquerading as brilliance.

Best Up And Coming Stocks To Watch For 2014: Southwest Airlines Co (LUV)

Southwest Airlines Co., incorporated on March 9, 1967, operates Southwest Airlines, a passenger airline, which provides scheduled air transportation in the United States. As of December 31, 2011, the Company was serving 72 cities in 37 states throughout the United States. During the year ended December 31, 2011, the Company added addition services in two new states and three new cities: Charleston, South Carolina; Greenville-Spartanburg, South Carolina; and Newark, New Jersey. Southwest provides point-to-point. On May 2, 2011, the Company acquired AirTran Holdings, Inc. (AirTran).

AirTran�� route system provides hub-and-spoke, rather than point-to-point, service, with approximately half of AirTran�� flights originating or terminating at its hub in Atlanta, Georgia. AirTran also serves a range of markets with non-stop service from bases of operation in Baltimore, Maryland; Milwaukee, Wisconsin; and Orlando, Florida. As of December 31, 2011, AirTran was serving 68 United States and near-international destinations, including San Juan, Puerto Rico; Cancun, Mexico; Montego Bay, Jamaica; Nassau, The Bahamas; Oranjestad, Aruba; Punta Cana, Dominican Republic, and Bermuda. As of January 31, 2012, AirTran served 65 destinations. During 2011, approximately 71% of Southwest�� customers flew non-stop, and Southwest�� average aircraft trip stage length was 664 miles with an average duration of approximately 1.8 hours.

As of December 31, 2011, Southwest offered 25 weekday roundtrips from Dallas Love Field to Houston Hobby, 13 weekday roundtrips from Phoenix to Las Vegas, 13 weekday roundtrips from Burbank to Oakland, and 12 weekday roundtrips from Los Angeles International to Oakland. Southwest offers connecting service opportunities from over 60 Southwest cities to different Volaris airports in Mexico including Aguascalientes, Guadalajara, Mexico City (MEX), Mexico City-Toluca (TLC), Morelia, and Zacatecas. The Company�� International Connect portal conducts two separate transac! tions: one with Southwest�� reservation system and one with Volaris�� reservation system.

Southwest bundles fares into three categories: Wanna Get Away, Anytime, and Business Select. Wanna Get Away fares are lowest fares. Business Select fares are refundable and changeable, and funds may be applied toward future travel on Southwest. Business Select fares also include additional perks, such as priority boarding, a frequent flyer point multiplier, priority security and ticket counter access in select airports, and one complimentary adult beverage coupon for the day of travel. The Company�� Internet Website, southwest.com, is the avenue for Southwest Customers to purchase tickets online. During 2011, southwest.com accounted for approximately 78% of all Southwest bookings. During 2011, approximately 84% of Southwest�� Passenger revenues came through its Website, including revenues from SWABIZ, the Company�� business travel reservation Web page.

Advisors' Opinion:

[By Jonas Elmerraji]
The same kind of setup is pinning down shares of Southwest Airlines (LUV) this week. In the bargain airline's case, resistance comes into play at $14.50, with support down at $12.50. Just like with Home Depot, the high probability trade is to bet in the same direction as the breakout from this rectangle.

Southwest has rallied 37.7% in 2013, a fact that isn't hugely surprising. Consolidation patterns are common -- if not necessary -- after such a big price move; they give traders a chance to catch their breath and figure out their next moves in shares of LUV. Look for the breakout as an indicator that they've made up their minds. A breakout in momentum through the 70 level should be a leading indicator that price action is going to follow suit.

I'd suggest putting alerts on both
[By Paul Ausick]
American Airlines Group Inc. (NYSE: AAL) and Southwest Airlines Co. (NYSE: LUV) have not published revenue data or projections.

While Delta’s news is spreading good cheer and rising share prices today, all the airlines are wary of a coming increase in a federal tax they pay to support the U.S. Transportation Safety Administration (TSA). Congress approved an increase to the fees paid to the TSA as part of the budget deal it reached last month.

Best Up And Coming Stocks To Watch For 2014: Optimer Pharmaceuticals Inc.(OPTR)

Optimer Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing hospital specialty products worldwide. It develops products that treat gastrointestinal infections and related diseases. The company provides two late-stage anti-infective product candidates, including Fidaxomicin, a narrow spectrum antibiotic for the treatment of Clostridium difficile-infection, which completed two Phase 3 trials; and Pruvel, a prodrug in the fluoroquinolone class of antibiotics, has completed two Phase 3 trials for the treatment of infectious diarrhea, including traveler?s diarrhea. It also develops product candidates using its proprietary technology Optimer One-Pot Synthesis, a computer-aided technology that enables the rapid synthesis of various proprietary molecules. In addition, the company?s other pipeline product candidates consist of CEM-101 (OP-1068), a macrolide and ketolide antibiotic, which is in Phase 2 trials for the treatment of upper and lower respiratory tract infections; and OPT-822/821, a novel carbohydrate-based cancer immunotherapy, is in Phase 2/3 trials for the treatment of metastatic breast cancer. It has collaborative agreements with Astellas Pharma Europe Ltd.; Par Pharmaceuticals, Inc.; Nippon Shinyaku, Co., Ltd.; Cempra Pharmaceuticals, Inc.; Memorial Sloan-Kettering Cancer Center; and The Scripps Research Institute. Optimer Pharmaceuticals, Inc. was founded in 1998 and is based in San Diego, California.

Advisors' Opinion:

[By Keith Speights]
"Bidness" is good (part 2)
Obagi isn't the only company for which "bidness" is good. Antibiotic maker�Optimer Pharmaceuticals (NASDAQ: OPTR ) shares soared 22% this week on talk of interest by multiple potential buyers.

Hot Cheap Stocks For 2014: Lakes Entertainment Inc.(LACO)

Lakes Entertainment, Inc., together with its subsidiaries, develops, finances, and manages Indian owned casino properties. It has development and management or financing agreements with three separate tribes for casino operations in Michigan and California. The company manages the Red Hawk Casino for the Shingle Springs Band of Miwok Indians situated in El Dorado County, California, which features 2,200 slot machines, 70 table games, 7 poker tables, 5 restaurants, 4 bars, retail space, a parking garage, and a child care facility and arcade. It also develops and finances a casino to be built on the reservation of the Jamul Indian Village located to the east of San Diego, California. In addition, Lakes Entertainment, Inc. engages in developing, financing, and managing non-Indian casino projects in Florida, Maryland, Mississippi, and Ohio. The company was formerly known as Lakes Gaming, Inc. and changed its name to Lakes Entertainment, Inc. in 2002. Lakes Entertainment, Inc. was founded in 1998 and is based in Minnetonka, Minnesota.

Advisors' Opinion:

[By John Emerson]
I will conclude Part one of Reflections from 20 Years of Investing (2001- 2008) with the discussion of three more sizable winners: Forward Industries (FORD), Lake Gaming (LACO) and Fairchild (FA).

Best Up And Coming Stocks To Watch For 2014: BNP Paribas SA (BNP)

BNP Paribas SA is a France-based bank group with four core businesses: Retail Banking, Corporate & Investment Banking, Investment Solutions and Other Activities. Retail Banking comprises the French retail banking division, Banca Nazionale del Lavoro in Italy, BeLux Retail Banking, Europe-Mediterranean, all BNP Paribas Group retail banking businesses out of Euro Zone: in the United States, in Asia, in the Mediterranean Basin and Africa, in Turkey, Central and Eastern Europe, personal finance and equipment solutions. The Corporate & Investment Banking business provides to its clients financing, advisory and capital markets services. The Investment Solutions division offers private banking, asset management, securities services, real estate and insurance services. In November 2013, the Company launched 'Hello Bank!', a mobile, digital bank operating in France, Belgium and Germany. Advisors' Opinion:

[By Namitha Jagadeesh]
BNP Paribas SA (BNP), Societe Generale SA (GLE) and Credit Agricole SA (ACA), France�� largest banks by market value, reported second-quarter profit that exceeded analysts��estimates. Paris-based Societe Generale, which said income more than doubled from a year earlier, trades at 10.8 times projected earnings, 64 percent below its 2009 high. Credit Agricole trades at 8.6 times projected profit and BNP Paribas at 10.7 times, according to data compiled by Bloomberg.

Best Up And Coming Stocks To Watch For 2014: Five Prime Therapeutics Inc (FPRX)

Five Prime Therapeutics, Inc., incorporated on December 20, 2001, is a clinical-stage biotechnology company focused on discovering and developing protein therapeutics. Protein therapeutics is antibodies or drugs developed from extracellular proteins or protein fragments that block disease processes, including cancer and inflammatory diseases. The Company�� advanced product candidates include FP-1039/GSK3052230 (FP-1039), FPA008 and FPA144. FP-1039 is a protein therapeutic that traps and neutralizes cancer-promoting fibroblast growth factors (FGFs), involved in cancer cell proliferation and new blood vessel formation. FPA008 is an antibody that inhibits colony stimulating factor-1 receptor (CSF1R), and is being developed to treat patients with inflammatory diseases, including rheumatoid arthritis (RA). FPA144 is an antibody that inhibits FGF receptor 2b (FGFR2b), and is being developed to treat patients with gastric cancer and potentially other solid tumors.

FP-1039

FP-1039 is a protein therapeutic, which includes the extracellular part of FGFR1. FP-1039 acts as an inhibitor of FGFs, because the FGFR1 portion of the molecule binds to FGFs and prevents them from binding to FGFR1 on tumor and blood vessel cells. Because FGF proteins circulating in the blood are called ligands, FP-1039 is called a ligand trap. FP-1039 also includes a portion of an antibody called the Fc region. In preclinical testing, it observed inhibition of tumor growth with single-agent FP-1039, particularly in tumors withFGFR1 gene amplification, including squamous NSCLC and SCLC.

FPA008

FPA008 is an antibody that inhibits CSF1R and is being developed to treat patients with RA. FPA008 also has the potential to treat patients with other inflammatory diseases, including lupus nephritis, psoriatic arthritis, ankylosing spondylitis, fibrosis, inflammatory bowel disease and multiple sclerosis. These are chronic, incurable disorders with serious medical complications and disability for ! which better therapies with novel mechanisms of action are needed. FPA008 is an anti-CSF1R antibody, which it designed to block the ability of IL-34 and CSF1 to bind to and activate CSF1R. FPA008 reduces the numbers and activity of monocytes and macrophages that cause disease, and prevents the production and release of inflammatory factors. The Company and others has demonstrated that both IL-34 and CSF1 are present at increased levels in the inflamed joints of patients with RA.

FPA144

FPA144 is a monoclonal antibody directed against a form of FGFR2, or FGFR2b. When the FGFR2 gene is amplified by cancer cells, the FGFR2b protein is expressed at abnormally high levels on the tumor�� surface. This occurs in some patients with gastric and lower esophageal cancers. The tumor cells that have too much FGFR2b protein on their surface can be identified by special staining tests performed on the tumor. Because FGFR2b is the target for FPA144, patients��tumors can be screened for this protein, helping to identify the patients most likely to respond to FPA144 treatment.

Advisors' Opinion:

[By John Kell and Tess Stynes var popups = dojo.query(".socialByline .popC"); p]
Among the companies with shares expected to actively trade in Monday’s session are Keurig Green Mountain Inc.(GMCR), JA Solar Holdings Co.(JASO) and Five Prime Therapeutics Inc.(FPRX)
[By Monica Gerson]
Breaking news
Alcoa (NYSE: AA) is investing US$13 million to expand its wheel manufacturing plant in Europe, to meet growing demand for its lightweight, durable, low-maintenance aluminum truck wheels. To read the full news, click here. L & L Energy (NASDAQ: LLEN) announced today that its Special Independent Committee has appointed Mr. Nicholas Chen, Managing Partner at Pamir Law Group, to replace Mr. Mark Bartlett. To read the full news, click here. Five Prime Therapeutics (NASDAQ: FPRX) and Bristol-Myers Squibb (NYSE: BMY) announced today that they have signed a collaboration agreement for the discovery, development and commercialization of immuno-oncology therapies directed toward targets identified in two undisclosed immune checkpoint pathways using Five Prime's proprietary target discovery platform. To read the full news, click here. First Solar (NASDAQ: FSLR) on Sunday announced the completion of the 1.3MW(DC) solar photovoltaic (PV) power plant at Kitakyushu-shi. Powered by First Solar FS Series 3 Black PV modules, the plant will generate approximately 1,400 MWh of clean and safe solar electricity per year. To read the full news, click here.
Posted-In: Credit Suisse US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets

Best Up And Coming Stocks To Watch For 2014: Nordson Corporation(NDSN)

Nordson Corporation manufactures equipment used for precision dispensing, testing and inspection, and surface preparation and curing. Its Adhesive Dispensing Systems segment manufactures equipment for applying adhesives, lotions, and liquids to disposable products; automated adhesive dispensing systems for the food and beverage, and packaged goods industries; hot melt and cold glue adhesive dispensing systems for the paper and paperboard converting industries; adhesive and sealant dispensing systems for bonding or sealing plastic, metal, and wood products; and laminating and coating systems to manufacture continuous-roll goods in the nonwovens, textile, paper, and flexible-packaging industries. The company?s Advanced Technology Systems segment comprises automated gas plasma treatment systems used to clean and condition surfaces for the semiconductor, medical, and printed circuit board industries; controlled manual and automated systems for applying materials in customer pr ocesses requiring precision and material conservation; ultraviolet equipment used in curing and drying operations for specialty coatings, semiconductor materials, and paints; and bond testing and automated optical and x-ray inspection systems used in the semiconductor and printed circuit board industries. Its Industrial Coating Systems segment provides automated and manual dispensing systems used for applying coatings, paint, finishes, sealants, and other materials. Nordson Corporation markets its products in the United States and internationally through a direct sales force, as well as through qualified distributors and sales representatives. It serves various markets, including the appliance, automotive, bookbinding, container, converting, electronics, food and beverage, furniture, life sciences and medical, metal finishing, non woven, packaging, and semiconductor industries. The company was founded in 1935 and is headquartered in Westlake, Ohio.

Advisors' Opinion:

[By Travis Hoium]
What: Shares of industrial product manufacturer Nordson (NASDAQ: NDSN ) dropped as much as 10% today after the company reported fiscal second-quarter earnings.
[By Lauren Pollock]
Nordson Corp.'s(NDSN) fiscal fourth-quarter earnings fell 12% on weaker demand, though the maker of dispensing equipment noted improvement in recent order trends.

Best Up And Coming Stocks To Watch For 2014: 8x8 Inc(EGHT)

8x8, Inc. develops and markets telecommunications services for Internet protocol (IP), telephony, and video applications. The company offers 8x8 Virtual Office Business Telephone Service, an alternative to traditional private branch exchange systems that offers automated attendants to assist callers; extension-to-extension dialing services; direct inward dial; conference bridge, 3-way calling, music on hold, call park/pick-up, call transfer, hunt groups, and do not disturb services; voice mail, including email alerts and direct transfer to mailbox; call waiting/caller-ID; distinctive tone ringing; and optional receptionist console applications. Its products also include 8x8 Complete Contact Center, an integrated hosted call center solution that consists of skill-based routing, multi-media management, real time monitoring and reporting, voice recording and logging, historical reporting, interactive voice response, CRM integration, and contact and case management tools; 8x8 IP Telephones; 8x8 Virtual Meeting, a video Web conferencing service; and 8x8 Managed Hosting and Cloud-Based Computing Solutions. In addition, the company offers 8x8 Virtual Office Pro Unified Communications that allows subscribers to manage business communications functions online and delivers various tools, such as Microsoft Outlook contacts and corporate directory integration; virtual meeting; Virtual Office Mobile extension; fax; call recording; presence management; and a view of voicemails, recordings, FAX messages, calls, and chat history. The company markets its services under 8x8 brand to end users through direct sales force, Web site, and third party resellers primarily in the United States. As of June 30, 2011, it had approximately 25,000 business customers. 8x8, Inc. was founded in 1987 and is headquartered in Sunnyvale, California.

Advisors' Opinion:

[By Anna Prior]
Cloud communication provider 8x8 Inc.(EGHT) agreed to acquire privately held U.K.-based Voicenet Solutions for $18.4 million in cash. Shares fell 4.7% to $10.14 in light premarket trading.
[By Jake L'Ecuyer]
8x8 (NASDAQ: EGHT) was also up, gaining 7.81 percent to $10.22 after Bank of America initiated coverage on the stock with a Buy rating and a $13.00 price target.

Best Up And Coming Stocks To Watch For 2014: Transdigm Group Incorporated(TDG)

TransDigm Group Incorporated designs, produces, and supplies engineered aircraft components for use on commercial and military aircraft principally in the United States. The company?s products include mechanical/electro-mechanical actuators and controls, ignition systems and engine technology, pumps and valves, power conditioning devices, AC/DC electric motors and generators, NiCad batteries and chargers, engineered latching and locking devices, rods and locking devices, engineered connectors and elastomers, cockpit security components and systems, cockpit displays, aircraft audio systems, lavatory components, engineered interior surfaces, and lighting and control technology. Its customers comprise distributors of aerospace components; commercial airlines, including national and regional airlines; commercial transport and regional and business aircraft original equipment manufacturers (OEMs); various armed forces of the United States and foreign governments; defense OEMs; system suppliers; and various other industrial customers. TransDigm Group Incorporated was founded in 1993 and is based in Cleveland, Ohio.

Advisors' Opinion:

[By Monica Wolfe]
TransDigm Group (TDG)
Fournier maintains his largest position in TransDigm Group where he holds 2,152,710 shares. His position in TransDigm represents 4.30% of the company�� shares outstanding and 6.3% of his total portfolio.
[By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on TransDigm Group (NYSE: TDG ) , whose recent revenue and earnings are plotted below.
[By Rich Smith]
Cleveland-based TransDigm Group (NYSE: TDG ) is buying a piece of GE.

On Friday, as trading wound down for the week, TransDigm announced a deal to buy the Electromechanical Actuation Division of General Electric (NYSE: GE ) Aviation for $150 million, cash. The business, which makes proprietary, highly engineered aerospace electromechanical motion control subsystems for civil and military applications, counts all three of the world's biggest airplane manufacturers -- Boeing, Airbus, and Brazil's Embraer -- among its clients, and Sikorsky and General Atomics, as well, on the military side.
[By Eric Volkman]
TransDigm (NYSE: TDG ) is rewarding its shareholders mightily with an extraordinary payout. The company has declared a special dividend of $22.00 per share, which will be paid on July 25 to shareholders of record as of July 15.

Best Up And Coming Stocks To Watch For 2014: Ikanos Communications Inc.(IKAN)

Ikanos Communications, Inc. provides broadband semiconductor and software products for the digital home. The company develops and markets end-to-end products for the last mile and the digital home, which enable carriers to offer triple play services, including voice, video, and data. It offers broadband digital subscriber line (DSL) products, such as high-density and low-power asymmetric DSL, and very-high-bit rate DSL products; communications processors that support various wide area network topologies, including passive optical network, DSL, wireless broadband, and Ethernet; and other products for access infrastructure and customer premises equipment (CPE) to network equipment manufacturers and telecommunications service providers. The company?s products comprise digital subscriber line access multiplexers, optical network terminals, concentrators, modems, voice over Internet protocol terminal adapters, integrated access devices, and residential gateways. It primarily s erves original design manufacturers, contract manufacturers, network equipment manufacturers, and original equipment manufacturers through direct sales and third-party sales representatives worldwide. The company was formerly known as Velocity Communications and changed its name to Ikanos Communications, Inc. in December 2000. Ikanos Communications, Inc. was incorporated in 1999 and is headquartered in Fremont, California.

Advisors' Opinion:

[By Victor Selva]
On Dec.24, Mario Gabelli, the Chairman and Chief Executive Officer of GAMCO Investors, Inc. added Communications Systems Inc. (JCS) at an average price of $11.05 and currently holds 330,172 shares of the stock. It was the 5th time he added the stock during this year, which makes me feel that he is betting in favor of a positive future for the consumption of network capacity.
Recommendations of the Board
Communications Systems is engaged in the manufacture and sale of modular connecting and wiring devices for voice and data communications, digital subscriber line filters, and structured wiring systems, and through its Transition Networks business unit in the manufacture of media and rate conversion products for telecommunications networks.
Few months ago the firm announced�a series of actions to increase revenues and improve profitability. The first change was to operate as a holding company, monitoring and supporting all the business units: Suttle, Transition Networks (TN) unit and JDL Technologies. With this ��ew format�� each unit will operate with a high degree of autonomy. This will result in the reduction of labor costs, the emphasizing of accountability in the units as well as better recognition of performance. "While difficult decisions for the Board, we believe the changes we have taken to restructure our parent company as a holding company and to focus on individual business unit performance is in the best interest of our shareholders and will increase shareholder value" said Curtis A. Sampson, the Company's Board Chair and Interim CEO. Furthermore, strategic investments in the TN unit such as marketing, sales and product development will boost revenues in the future.
Severe Warning Signs
Not all are good news, we found three severe warning signs issued by GuruFocus: Piotroski F-Score of 2 is low, which usually implies poor business operation; revenue has been in decline over the past 3 years and operating margin has been in 5-year

Best Up And Coming Stocks To Watch For 2014: C&F Financial Corporation(CFFI)

C&F Financial Corporation operates as the holding company for Citizens and Farmers Bank that provides various banking and related financial services to individuals and businesses. It operates through three segments: Retail Banking, Mortgage Banking, and Consumer Finance. The Retail Banking segment offers various types of checking and savings deposit accounts; business, real estate, development, mortgage, home equity, and installment loans; and ATMs, Internet banking, and credit cards, as well as travelers? checks, safe deposit box rentals, collection, notary public, wire service, and other customary bank services. This segment provides retail banking services at its main office in West Point, Virginia; and 17 branches in Chester, Hampton, Mechanicsville, Midlothian, Newport News, Norge, Providence Forge, Quinton, Saluda, Sandston, Varina, West Point, Yorktown, Williamsburg, and Richmond, Virginia. The Mortgage Banking segment originates conventional mortgage loans, mortga ge loans insured by the Federal Housing Administration, mortgage loans partially guaranteed by the Veterans Administration, and home equity loans. This segment provides mortgage loan origination services through 15 locations in Virginia, 4 in Maryland, and 2 in North Carolina, as well as 1 each in Wilmington, Delaware; Moorestown, New Jersey; and York, Pennsylvania. The Consumer Finance segment provides automobile loans in Virginia and in portions of Alabama, Indiana, Kentucky, Maryland, North Carolina, Ohio, Tennessee, Georgia, and West Virginia through offices in Richmond and Hampton, Virginia; Nashville, Tennessee; and Towson, Maryland. The company also offers brokerage services, and insurance and title insurance services. C&F Financial Corporation was founded in 1927 and is based in West Point, Virginia.

Advisors' Opinion:

[By Doug Hughes]
An example of that would be C&F Financial (CFFI) in Westport, Virginia. The CEO, Larry Dillon, has been there for 35 years, plus, the bank is trading at a p/e of 6 or 7, if you can believe it. It's only $2 over book value.

Saturday, March 15, 2014

Hot Mid Cap Stocks To Buy Right Now

Hot Mid Cap Stocks To Buy Right Now: South Jersey Industries Inc.(SJI)

South Jersey Industries, Inc., through its subsidiaries, engages in the purchase, transmission, and sale of natural gas for residential, commercial, and industrial customers. It also sells natural gas and pipeline transportation capacity on a wholesale basis to various customers on the interstate pipeline system, as well as transports natural gas purchased directly from producers or suppliers to their customers. In addition, it markets natural gas storage, commodity, and transportation assets on a wholesale basis for energy marketers, electric and gas utilities, and natural gas producers in the mid-Atlantic, Appalachian, and southern regions of the United States. Further, the company develops and operates energy-related projects, which provide cooling, heating, and emergency power; and operates landfill gas-fired electric production facilities and solar projects. Additionally, it provides services for the acquisition and transportation of natural gas and electricity for re tail end users; markets total energy management services; installs and services residential and light commercial HVAC systems; provides plumbing services; and services appliances, as well as offers meter reading services. As of December 31, 2010, the company served 347,725 residential, commercial, and industrial customers primarily in southern New Jersey. The company was founded in 1910 and is headquartered in Folsom, New Jersey.

Advisors' Opinion:

[By Marc Bastow]
Energy services holding company South Jersey Industries (SJI) raised its quarterly dividend 6.7% to 47.25 cents per share, payable on Dec. 27 to shareholders of record as of Dec. 10. The increase marks the 15th consecutive increase to the annual dividend.
SJI Dividend Yield: 3.41%

source from Top Stocks Blog! :http://www.topstocksblog.com/hot-mid-cap-stocks-to-buy-right-now.html